Tofacitinib Impurity 90 | CAS 2504210-45-9 - Request Quote
Tofacitinib Impurity 90
| SZ CAT No: | SZ-T010174 |
| CAS No | 2504210-45-9 |
| Mol.F. | C12H5Cl3N6 |
| Mol.Wt. |
339.6 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib Impurity 90 is chemically 2,2',4'-Trichloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine. Tofacitinib Impurity 90 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Impurity 90 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2504210-45-9
Purchase 2504210-45-9
Order 2504210-45-9
Enquire 2504210-45-9
price of 2504210-45-9
2504210-45-9 Supplier
2504210-45-9 Manufacturer
2504210-45-9 Exporter
buy high quality Tofacitinib Impurity 90
Purchase Tofacitinib Impurity 90
Tofacitinib Impurity 90 suppliers
Tofacitinib Impurity 90 manufacturers
Tofacitinib Impurity 90 price
Order Tofacitinib Impurity 90
Enquire Tofacitinib Impurity 90
Tofacitinib Impurity 90 cost
Tofacitinib Impurity 90 Supplier
Tofacitinib Impurity 90 Distributor
Tofacitinib Impurity 90 for Method Validation
Tofacitinib Reference Standard
Tofacitinib Impurity 90 for ANDA Filing
Tofacitinib Impurity 90 for Forced Degradation Studies
Tofacitinib Impurity 90 Identification Standards
Tofacitinib Impurity 90 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.